“It is reasonable to predict that Ohio would collect hundreds of millions in annual cannabis tax revenues from a mature adult-use cannabis market.”
By Jake Zuckerman, Ohio Capital Journal
Recreational marijuana in Ohio could mean up to $375 million in annual tax revenue for the state, according to new research from Ohio State University.
The study, released just in time for America’s annual, informal marijuana celebration day Wednesday, uses tax estimates from an initiated statute effort to legalize marijuana in the state, possibly via the November 2022 ballot.
The study pairs tax rates (10 percent in addition to Ohio’s 5.75 percent state sales tax) from the organizers’ proposal, population growth estimates and year-over-year revenue data from six other states (Michigan, Illinois, Nevada, Oregon, Washington and Colorado) with recreational programs to make projections for Ohio.
What tax revenues should Ohioans expect if Ohio legalizes adult-use cannabis? Our latest policy paper provides an initial estimate of potential cannabis tax revenue in Ohio, informed by data and trends from a select group of other states.
Depending on the bullishness of growth estimates and product pricing, the researchers estimated the state will earn somewhere between $276 million to $375 million by the fifth year of operation.
“Whatever tax structure is adopted, our analysis suggests it is reasonable to predict that Ohio would collect hundreds of millions in annual cannabis tax revenues from a mature adult-use cannabis market,” the researchers, from OSU’s Drug Enforcement and Policy Center concluded. “But the amount of tax revenue collected would likely still represent a small percentage of Ohio’s $60+ billion annual budget.”
The study notes its limitations—it calls its analysis a “best guess” based on consumption patterns, price, tax structure, program rollout, regulatory hiccups and others.
Organizers gathered about 133,000 signatures to force state lawmakers, over the course of about four months ending in late May, to consider their proposed legislation to legalize the drug for adult sales and use. If lawmakers decline to pass the proposal, the organizers must gather the same amount of signatures again and then can place the issue on the general election ballot in November.